Search filters
Filters
Clear All

Phase

  • 182
  • 151
  • 2
  • 188
  • 147
  • 17
  • 373
  • 1196
  • 568
  • 28
  • 44
  • 2
  • 1128
  • 1197
  • 5

Found 1202 All Conditions trials

A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Study to establish the safety of reducing radiation dose in selected p16+ OPSCC patients receiving adjuvant radiation after Transoral Robotic Surgery (TORS) and neck dissection

18 years - 99 years
All genders
Phase 2
Interventional
The main purpose of this research study is to determine the likelihood of cancer growing back in the throat or in the neck, 2 years after completion of radiation, if lower doses of radiation are used to a smaller area of the head and neck region, than is currently the …
Learn More

Study To Assess Efficacy Safety And Pharmacokinetics Of Iptacopan (LNP023) In Participants With Autoimmune Benign Hematological Disorders

99 years or below
All genders
Phase 2
Interventional
The main purpose of this study is to evaluate the efficacy and safety of the investigational drug iptacopan (LNP023) in people with primary ITP or primary CAD. You will be in the study about 6 months with the opportunity to extend the total duration to about 31 months if you …
Learn More

Study of SynKIR-110 Autologous T cells Transduced with Mesothelin KIR-CAR in Subjects with Mesothelin-Expressing Advanced Ovarian Cancer Cholangiocarcinoma or Mesothelioma

18 years - 99 years
All genders
Phase 1
Interventional
This study involves research of an investigational therapy called SynKIR-110. SynKIR-110 is CAR T cell therapy. CAR T cell therapy is a type of treatment in which a patient’s T cells (white blood cells that are a part of the immune system) are changed in a laboratory so they can …
Learn More

Study to Evaluate Study Drug XmAb 20717 in Subjects with Selected Advanced Solid Tumors (DUET-2)

18 years - 99 years
All genders
The primary purposes of this research study are to determine the safety and tolerability of dose levels of the investigational drug, XmAb20717, and if XmAb20717 works in treating advanced solid tumors that have progressed after treatment with standard cancer therapies or solid tumors for which there are no appropriate therapies …
Learn More

Uncovering the etiologies of non-immune hydrops fetalis through comprehensive genomic analyses and phenotyping

99 years or below
Female
The goal of this study is to better understand the genetic causes of non-immune hydrops fetalis (NIHF) and other types of abnormal fluid collections with genomic sequencing, detailed review of clinical information, and in some cases, additional research testing. As NIHF and other types of abnormal fluid collections are often …
Learn More

ABC 123 July

99 years or below
All genders
This post-market, prospective, interventional, global, multi-center, randomized, nonblinded, dual-arm, clinical trial study will generate clinical evidence related to key performance outcomes of Endurant II/IIs Stent Graft System versus Gore Excluder/Excluder Conformable AAA Endoprosthesis in subjects with Abdominal Aortic Aneurysm (AAA). The primary objective is to evaluate sac regression outcomes in …
Learn More

prescreener Trial

100 years or below
Male
This trial is of the prescreener .
Check Eligibility

July 2023 3

99 years or below
Male
Phase 1
This post-market, prospective, interventional, global, multi-center, randomized, nonblinded, dual-arm, clinical trial study will generate clinical evidence related to key performance outcomes of Endurant II/IIs Stent Graft System versus Gore Excluder/Excluder Conformable AAA Endoprosthesis in subjects with Abdominal Aortic Aneurysm (AAA). The primary objective is to evaluate sac regression outcomes in …
Learn More

July 2023 4

99 years or below
Male
Phase 1
This post-market, prospective, interventional, global, multi-center, randomized, nonblinded, dual-arm, clinical trial study will generate clinical evidence related to key performance outcomes of Endurant II/IIs Stent Graft System versus Gore Excluder/Excluder Conformable AAA Endoprosthesis in subjects with Abdominal Aortic Aneurysm (AAA). The primary objective is to evaluate sac regression outcomes in …
Learn More

July 2023 5

99 years or below
Male
Phase 1
This post-market, prospective, interventional, global, multi-center, randomized, nonblinded, dual-arm, clinical trial study will generate clinical evidence related to key performance outcomes of Endurant II/IIs Stent Graft System versus Gore Excluder/Excluder Conformable AAA Endoprosthesis in subjects with Abdominal Aortic Aneurysm (AAA). The primary objective is to evaluate sac regression outcomes in …
Learn More
1091 - 1100 of 1202